Anthony Marotta
Keine laufenden Positionen mehr
Profil
Anthony Marotta founded Augurex Life Sciences Corp.
in 2007, where he worked as Chief Scientific Officer from 2007 to 2013.
Dr. Marotta also formerly worked at Kinetek Pharmaceuticals, Inc., as Principal and Stressgen Bioreagents Corp., as Principal from 2004 to 2013.
Dr. Marotta received his doctorate degree from the University of British Columbia.
Ehemalige bekannte Positionen von Anthony Marotta
| Unternehmen | Position | Ende |
|---|---|---|
| Kinetek Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Stressgen Bioreagents Corp.
 Stressgen Bioreagents Corp. Medical/Nursing ServicesHealth Services Stressgen Bioreagents Corp. was engaged in expansion of product development program in the core areas of Cell Signaling and Phosphorylation. Its products were active kinases, phosphor-specific antibodies and StressXpress® kinase activity kits. Its research areas were including new kits, antibodies and proteins for Heat Shock, Apoptosis, Oxidative Stress and novel molecular biology tools. Stressgen Bioreagents was headquartered in Victoria, CA. | Corporate Officer/Principal | - |
Augurex Life Sciences Corp.
 Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada. | Gründer | - |
Ausbildung von Anthony Marotta
| University of British Columbia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Augurex Life Sciences Corp.
Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada. | Health Technology |
| Kinetek Pharmaceuticals, Inc. | Health Technology |
Stressgen Bioreagents Corp.
Stressgen Bioreagents Corp. Medical/Nursing ServicesHealth Services Stressgen Bioreagents Corp. was engaged in expansion of product development program in the core areas of Cell Signaling and Phosphorylation. Its products were active kinases, phosphor-specific antibodies and StressXpress® kinase activity kits. Its research areas were including new kits, antibodies and proteins for Heat Shock, Apoptosis, Oxidative Stress and novel molecular biology tools. Stressgen Bioreagents was headquartered in Victoria, CA. | Health Services |
